Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Time to Blood Culture Positivity as a Predictor of Clinical Outcome of Staphylococcus aureus Bloodstream Infection

Alexandre R. Marra, Michael B. Edmond, Betty A. Forbes, Richard P. Wenzel, Gonzalo M. L. Bearman
Alexandre R. Marra
1Department of Infectious Diseases, Universidade Federal de São Paulo, São Paulo, Brazil
2Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: a.marra@uol.com.br
Michael B. Edmond
2Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Betty A. Forbes
3Department of Pathology, Virginia Commonwealth University School of Medicine, Richmond, Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard P. Wenzel
2Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gonzalo M. L. Bearman
2Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.44.4.1342-1346.2006
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Few studies have assessed the time to blood culture positivity as a predictor of clinical outcome in bloodstream infections (BSIs). The purpose of this study was to evaluate the time to positivity (TTP) of blood cultures in patients with Staphylococcus aureus BSIs and to assess its impact on clinical outcome. We performed a historical cohort study with 91 adult patients with S. aureus BSIs. TTP was defined as the time between the start of incubation and the time that the automated alert signal indicating growth in the culture bottle sounded. Patients with BSIs and TTPs of culture of ≤12 h (n = 44) and >12 h (n = 47) were compared. Septic shock occurred in 13.6% of patients with TTPs of ≤12 h and in 8.5% of patients with TTP of >12 h (P = 0.51). A central venous catheter source was more common with a BSI TTP of ≤12 h (P = 0.010). Univariate analysis revealed that a Charlson score of ≥3, the failure of at least one organ (respiratory, cardiovascular, renal, hematologic, or hepatic), infection with methicillin-resistant S. aureus, and TTPs of ≤12 h were associated with death. Age, gender, an APACHE II score of ≥20 at BSI onset, inadequate empirical antibiotic therapy, hospital-acquired bacteremia, and endocarditis were not associated with mortality. Multivariate analysis revealed that independent predictors of hospital mortality were a Charlson score of ≥3 (odds ratio [OR], 14.4; 95% confidence interval [CI], 2.24 to 92.55), infection with methicillin-resistant S. aureus (OR, 9.3; 95% CI, 1.45 to 59.23), and TTPs of ≤12 h (OR, 6.9; 95% CI, 1.07 to 44.66). In this historical cohort study of BSIs due to S. aureus, a TTP of ≤12 h was a predictor of the clinical outcome.

The evaluation for bloodstream infection (BSI) is an important step in the workup of febrile patients (24). The majority of positive blood cultures are associated with true bloodstream infections (10), and a positive blood culture is frequently the trigger for the initiation of antimicrobial therapy (24).

Staphylococcus aureus is a highly common cause of BSIs (27). Moreover, mortality increases when inadequate empirical antibiotic therapy is given to patients with BSIs due to S. aureus (12). The rapid detection of a BSI has an impact on the length of hospitalization (2) and the mortality of bacteremic patients (4).

Physicians often make clinical predictions about individual patients (13). However, few studies have formally assessed the bacterial load (9), as indirectly measured as the time to positivity (TTP) of blood cultures, as a predictor of clinical outcome (14, 23).

The purpose of this study was to evaluate the association between the time to positivity of blood cultures in patients with S. aureus BSIs and the clinical outcome.

MATERIALS AND METHODS

Setting.The Virginia Commonwealth University Medical Center (VCUMC) is an 820-bed tertiary-care facility in Richmond, Virginia. The hospital houses nine intensive care units (ICUs), including pediatric ICUs and a burn unit. Approximately 30,000 patients are admitted annually.

Study design.Patients with BSIs at VCUMC from 15 December 2003 through 31 December 2004 were identified retrospectively by use of the electronic medical microbiology record. For each case, the time to blood culture positivity was retrieved from the hospital's automated blood culture instrument. The medical microbiology record identified the patient by medical record number so that a retrospective chart review could be conducted. Patients were considered to have had a BSI due to S. aureus if one or more blood cultures were positive for this organism. Each patient was included only once, at the time of the first BSI. Patients less than 18 years old, those with polymicrobial infections, and those receiving antimicrobial therapy at the time of the BSI were excluded from the analysis.

Data collected included age; gender; location of the patient (ward versus ICU); the duration of hospitalization prior to the onset of the BSI; the presence of predisposing clinical factors, including neutropenia (defined as an absolute neutrophil count of <500/μl); the use of peritoneal dialysis or hemodialysis; and the presence of central venous catheters. The sources of secondary BSIs were identified by cultures of samples obtained from the primary site of infection that yielded the same pathogen. Adverse outcomes (organ failure and in-hospital mortality) occurring during the course of hospitalization were recorded.

The severity of the underlying disease preceding the positive blood culture was classified by use of the Charlson weighted comorbidity index (6) and the McCabe classification (19). The patient's physiological condition on the day of the BSI was assessed by using the APACHE II score (15). At the onset of the BSI, the clinical condition of each patient was classified as systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, or septic shock by using criteria previously published by the American College of Chest Physicians/Society of Critical Care Medicine (1). SIRS was defined as two or more of the following: (i) a temperature of >38°C or <36°C, (ii) a heart rate of >90 beats per minute, (iii) a respiratory rate of >20 breaths per minute or a partial arterial CO2 pressure of <32 mm Hg, or (iv) a white blood cell count of >12 ×109/liter or <4 ×109/liter or the presence of more than 10% immature neutrophils.

Severe sepsis was defined as organ dysfunction, hypotension, or systemic manifestations of hypoperfusion. Septic shock was defined as sepsis associated with hypotension unresponsive to intravenous fluid challenge or the need for treatment with a vasopressor agent. The maximal inflammatory response was defined as severe sepsis, septic shock, or death. The presence of organ system failure at the time of the BSI and during the clinical course was assessed by using the criteria described by Fagon et al. (7). Nosocomial infection was defined as an infection that occurred >48 h after hospital admission, an infection that occurred <48 h after admission to the hospital for patients who had been hospitalized in the 3 weeks prior to the admission, or an infection that occurred <48 h after admission to the hospital for patients who had been transferred from another hospital or nursing home (8). The sources of infection were also defined according to Centers for Disease Control and Prevention criteria (8). Endocarditis was diagnosed by means of the modified Duke criteria (18). Time to positivity was defined as the time between the start of incubation and the time to sounding of the alert signal on the automated blood culture instrument. Adequate empirical antimicrobial treatment was defined as therapy that was administered within 24 h after samples for blood culture were obtained and that included any antimicrobial agent to which the S. aureus isolate was susceptible.

Microbiological methods.Blood cultures were processed by the institution's clinical laboratory using the BacT/ALERT blood culture instrument (bioMérieux, Durham, NC). Each blood culture set consisted of an FA aerobic bottle and an SN anaerobic bottle. All the samples of blood cultures were collected and submitted in a timely manner to the microbiology laboratory. All the bottles were loaded into the instrument at any time of the day (24 h a day, 7 days a week) without delay. The time to positivity of the first bottle in a set to be flagged as positive was used to determine the time to positivity and was obtained by using the system's software.

Statistical analysis.Continuous variables were compared by using the Student t test for normally distributed variables and the Mann-Whitney U test for nonnormally distributed variables. Differences in proportions were compared by a chi-square test or Fisher's exact test, when appropriate. Mean values ±1 standard deviation were reported. Alpha was set equal to 0.05, and all tests of significance were two tailed. When collinearity was identified between two variables in a correlation matrix, the one with the greatest clinical relevance associated with mortality was included in the multivariate analysis. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated for all variables. Variables found to be significant by univariate analysis were then entered into a multivariate model. All statistical analyses were done by using the Statistical Package for the Social Sciences software (SPSS, Inc., Chicago, IL).

RESULTS

Study population and patient characteristics.A total of 373 patients with clinically significant episodes of BSIs were identified at VCUMC during the 1-year study period. Of these, 294 patients (78.8%) had bacterial BSIs and 79 (21.2%) had fungal BSIs. A total of 113 patients (30.3%) with S. aureus BSIs were identified. Of these 113 patients, 18 patients were excluded because they were on antimicrobial therapy when blood samples for culture were obtained and 4 patients were excluded because they had polymicrobial BSIs. Only the remaining 91 patients were analyzed.

The mean age was 50 ± 15 years (range, 20 to 86 years). Twenty-four patients (26.4%) were over 60 years of age. The most frequent diagnoses responsible for hospitalization were infection (cellulitis, septic arthritis, and endocarditis) (31.9%), renal failure (19.8%), gastrointestinal diseases (15.4%), and solid and hematologic malignancies (13.2%). The most frequent sources of BSIs were central venous catheters (26.4%) and skin and soft tissues (13.2%). The average duration of hospitalization was 18 ± 14.8 days (range, 3 to 78 days). Most BSIs (63.7%) occurred during the first 48 h of hospitalization. Thirteen cases had been hospitalized less than 3 weeks previously (Table 1).

View this table:
  • View inline
  • View popup
TABLE 1.

Demographic characteristics of 91 adult patients with monomicrobial S. aureus BSIs

Time to positivity.The median time to positivity was 12.2 h. Because previous studies reported that the growth of S. aureus from endovascular sources within 14 h correlated with complications, we divided our study into two groups: patients with an early time to positivity (TTP of ≤12 h) and patients with a late time to positivity (TTP of >12 h). Associated risk factors and outcomes of the two TTP groups are summarized in Table 2. There were significant differences in age (P = 0.027) but not gender (P = 0.078) between the two groups. No statistically significant differences in the proportion of patients with end-stage renal disease, diabetes mellitus, or underlying malignancy were observed between the two TTP groups (P > 0.05). Endocarditis was more commonly associated with a BSI TTP of ≤12 h than with a BSI TTP of >12 h (25.0% and 8.5%, respectively; P = 0.048). Patients with early positive cultures were more likely to have more severe underlying disease (52.3% of patients with early positive cultures had a Charlson score of ≥3, whereas 29.8% of patients with late positive cultures had a Charlson score of ≥3; P = 0.029). All neutropenic patients (five cases) had TTPs <12 h (100.0%). Central venous catheters were also more commonly associated with a BSI TTP of ≤12 h than with a BSI TTP of >12 h (38.6% and 14.9%, respectively; P = 0.010). There were no differences in the nonintravascular catheter sources of BSIs between the two groups (P > 0.05). No statistically significant differences in the proportion of methicillin resistance in the S. aureus isolates between the two groups were observed (50.0% in the group with a TTP of ≤12 h and 42.6% in the group with a TTP of >12 h; P = 0.48).

View this table:
  • View inline
  • View popup
TABLE 2.

Risk factors for and outcomes associated with time to positivity (≤12 or >12 h) in S. aureus BSIs

Clinical course.Septic shock occurred in 13.6% of the group with a TTP of ≤12 h and in 8.5% of the group with a TTP of >12 h (P = 0.22). No statistically significant differences were observed in maximal SIRS (severe sepsis, septic shock, or death) between the two groups (20.5% in the group with a TTP of ≤12 h and 14.9% in the group with a TTP of >12 h; P = 0.59). Patients with a TTP of ≤12 h were significantly more likely to have an APACHE II score of ≥20 at BSI onset (39% versus 10.6% for the group with a TTP of >12 h; P = 0.010). No difference in hospital-acquired bacteremia was observed between the two groups (31.8% for the group with a TTP of ≤12 h versus 40.4% for the group with a TTP of >12 h; P = 0.39). Appropriate empirical antimicrobial use was documented in greater than 79.5% of the group with a TTP of ≤12 h; however, this was not statistically significant (79.5% in the group with a TTP of ≤12 h versus 61.7% in the group with a TTP of >12 h; P = 0.063). Patients with BSIs caused by methicillin-resistant S. aureus (MRSA) strains were more likely to have received inadequate empirical antimicrobial therapy (70.4% in MRSA-infected patients versus 29.6% in non-MRSA-infected patients; P = 0.003).

Hematologic failure was more commonly seen in the group with a TTP of ≤12 h (15.9% versus 2.1% for the group with a TTP of >12 h; P = 0.027). No significant differences in the incidence of respiratory, renal, and hepatic failures were noted between the two groups. The overall crude mortality was 14.3% (13 of 91 patients). In-hospital mortality was greater in the group with a TTP of ≤12 h than in the group with a TTP of >12 h TTP (25.0% and 4.3%, respectively; P = 0.006).

Univariate analysis revealed that a Charlson score of ≥3, the development of at least one organ system failure (respiratory, cardiovascular, renal, hematologic, or hepatic), infection with methicillin-resistant S. aureus, and time to positivity of ≤12 h were associated with death (Table 3). Age, gender, an APACHE II score ≥20 at BSI onset, inadequate empirical antibiotic therapy, hospital-acquired bacteremia, and endocarditis were not significant predictors of mortality on univariate analysis. By using logistic regression analysis, the following variables were found to be independent predictors of death (Table 3): Charlson score of ≥3 (OR, 14.4; 95% CI, 2.24 to 92.55), infection with methicillin-resistant S. aureus (OR, 9.3; 95% CI, 1.45 to 59.23), and a TTP of ≤12 h (OR, 6.9; 95% CI, 1.07 to 44.66).

View this table:
  • View inline
  • View popup
TABLE 3.

Risk factors for hospital mortality in patients with S. aureus BSIs

DISCUSSION

We studied the association of clinical outcome and time to positivity of blood cultures for S. aureus BSIs. Unlike prior studies, we did not investigate the utility of blood culture TTP as a diagnostic tool for catheter-related or endovascular S. aureus BSIs (5, 26).

During the study period, nearly half of the patients with S. aureus BSIs exhibited an early TTP of the blood culture (TTP < 12 h). These cases were associated with a sevenfold higher rate of mortality than those with TTPs later than 12 h. Prior studies have shown that the growth of S. aureus from endovascular sources within 14 h can predict complications and can possibly predict mortality (14). We found similar results; however, our investigation also controlled for other variables that could explain the rapid bacterial growth, such as underlying conditions (diabetes mellitus, neoplasia, end-stage renal disease), source of infection (intravascular catheter), and the severity of the patients' conditions related to the clinical course (APACHE II score and maximal inflammatory response).

Of interest, no differences in the inflammatory responses were observed between the two TTP groups. Additionally, no differences in blood culture TTP were observed in patients with diabetes mellitus, neoplasia, or end-stage renal disease. Prompt adequate antimicrobial therapy in the group with a TTP of ≤12 h may have favorably altered the outcomes in these patients (12).

A statistically significant difference in APACHE II scores was noted between the two TTP comparison groups at the onset of the S. aureus BSIs. A previous study by Khatib et al. showed that patients with early times to positivity were more acutely ill and subsequently developed greater clinical complications (14). However, that study did not control for the severity of the underlying illnesses. In our study, the Charlson weighted comorbidity index and serial APACHE II scores were used to assess the severities of the patients' illnesses. The impact of underlying disease, as measured by the Charlson weighted comorbidity index, in patients with BSIs due to S. aureus was reported previously (16). Although in our study the APACHE II score was not a predictor of mortality in patients with S. aureus BSIs, other authors have had different results (22, 28). Thus, after controlling for the severity of illness, an early time to positivity of the blood culture was associated with increased mortality.

By multivariate analysis we could demonstrate that patients who acquired a strain of methicillin-resistant S. aureus had a high mortality rate related to the BSI. Although previous studies (11, 17, 28) have reported no increase in the mortality rate from infections caused by resistant microorganisms, other studies have shown the opposite (20, 21, 25). Although our observations show that infection with methicillin-resistant S. aureus is a predictor for mortality in patients with BSIs, the importance of virulence factors and pathogenesis remains unclear. As well, the restricted therapeutic options available for the treatment of MRSA BSIs could explain the differences in mortality between patients with methicillin-susceptible and -resistant S. aureus bacteremia (3, 20). Patients with MRSA BSIs were more likely to have received inadequate empirical antimicrobial therapy (70.4% in MRSA-infected patients versus 29.6% in non-MRSA-infected patients; P = 0.003).

Our study is limited by the retrospective nature of our analysis. In addition, because of the relatively small sample size of our study (n = 91), a type II error could have occurred, which would limit the ability to detect a statistically significant difference in SIRS or organ failure as predictors of mortality.

In conclusion, among adult patients with monomicrobial S. aureus BSIs, almost one-half of the cases had a time to blood culture positivity of ≤12 h. An early TTP is associated with a significantly greater risk for mortality. TTP data are easily obtainable in hospitals where microbiology laboratories use automated blood culture detection methods. These data can assist clinicians with choosing the appropriate antimicrobial therapy as soon as possible and provide prognostic information for patients with S. aureus BSIs.

ACKNOWLEDGMENTS

This work was supported by CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brasilia, Brazil).

FOOTNOTES

    • Received 13 December 2005.
    • Returned for modification 23 January 2006.
    • Accepted 25 January 2006.
  • Copyright © 2006 American Society for Microbiology

REFERENCES

  1. 1.↵
    American College of Chest Physicians/Society of Critical Care Medicine. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med.20:864-874.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    Beekmann, S. E., D. J. Diekema, K. C. Chapin, and G. V. Doern. 2003. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. J. Clin. Microbiol.41:3119-3125.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Blot, S. I., K. H. Vandewoude, E. A. Hoste, and F. A. Colardyn. 2002. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch. Intern. Med.162:2229-2235.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    Byl, B., P. Clevenbergh, F. Jacobs, M. J. Struelens, F. Zech, A. Kentos, and J. P. Thys. 1999. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin. Infect. Dis.29:60-66.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    Catton, J. A., B. M. Dobbins, P. Kite, J. M. Wood, K. Eastwook, S. Sugden, J. A. T. Sandoe, D. Burke, M. J. McMahon, and M. H. Wilcox. 2005. In situ diagnosis of intravascular catheter-related bloodstream infection: a comparison of quantitative culture, differential time to positivity, and endoluminal brushing. Crit. Care Med.33:787-791.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    Charlson, M. E., P. Pompei, K. L. Ales, and C. R. MacKenzie. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis.40:373-383.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Fagon, J. Y., J. Chastre, A. Novara, P. Medioni, and C. Gibert. 1993. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med.19:137-144.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    Garner, J. S., W. R. Jarvis, T. B. Emori, T. C. Horan, and J. M. Hughes. 1988. CDC definitions for nosocomial infections. Am. J. Infect. Control16:128-140.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    Hackett, S. J., M. Guiver, J. Marsh, J. A. Sills, A. P. Thomson, E. B. Kaczmarski, and C. A. Hart. 2002. Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch. Dis. Child.86:449-452.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Haimi-Cohen, Y., S. Shafinoori, V. Tucci, and L. G. Rubin. 2003. Use of incubation time to detection in Bactec 9240 to distinguish coagulase-negative staphylococcal contamination from infection in pediatric blood cultures. Pediatr. Infect. Dis. J.22:968-973.
    OpenUrlPubMed
  11. 11.↵
    Harbarth, S., O. Rutschmann, P. Sudre, and D. Pittet. 1998. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch. Intern. Med.158:182-189.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    Ibrahim, E. H., G. Sherman, S. Ward, V. J Fraser, and M. H. Kollef. 2000. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest118:9-11.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Juthani-Mehta, M., and V. J. Quagliarello. 2004. Prognostic scoring systems for infectious diseases: their applicability to the care of older adults. Clin. Infect. Dis.38:692-696.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    Khatib, R., K. Riederer, S. Saeed, L. B. Johnson, M. G. Fakih, M. Sharma, M. S. Tabriz, and A. Khosrovaneh. 2005. Time to positivity in Staphylococcus aureus bacteremia: possible correlation with source and outcome of infection. Clin. Infect. Dis.41:594-598.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    Knaus, W. A., E. A. Draper, D. P. Wagner, and J. E. Zimmerman. 1985. APACHE II: a severity of disease classification system. Crit. Care Med.13:818-829.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    Lesens, O., C. Methlin, Y. Hansmann, V. Remy, M. Martinot, C. Bergin, P. Meyer, and D. Christmann. 2003. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect. Control Hosp. Epidemiol.24:890-896.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    Lewis, E., and L. D. Saravolatz. 1985. Comparison of methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia. Am. J. Infect. Control13:109-114.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    Li, J. S., D. J. Sexton, N. Mick, R. Nettles, V. G. Fowler, Jr., T. Ryan, T. Bashore, and G. R. Corey. 2000. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin. Infect. Dis.30:633-638.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    McCabe, W. R., and G. G. Jackson. 1965. Treatment of pyelonephritis: bacterial, drug and host factors in success or failure among 252 patients. N. Engl. J. Med.272:137-144.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    Melzer, M., S. J. Eykyn, W. R. Gransden, and S. Chinn. 2003. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin. Infect. Dis.37:1453-1460.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    Moreira, M., E. A. Medeiros, A. C. Pignatari, S. B. Wey, and D. M. Cardo. 1998. Effect of nosocomial bacteremia caused by oxacillin-resistant Staphylococcus aureus on mortality and length of hospitalization. Rev. Assoc. Med. Bras.44:263-268.
    OpenUrlPubMed
  22. 22.↵
    Mylotte, J. M., and A. Tayara. 2000. Staphylococcus bacteremia: predictors of 30-day mortality in a large cohort. Clin. Infect. Dis.31:1170-1174.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    Norris, C. F., K. Smith-Whitley, and K. L. McGowan. 2003. Positive blood cultures in sickle cell disease: time to positivity and clinical outcome. J. Pediatr. Hematol. Oncol.25:390-395.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    Peters, R. P. H., M. A. van Agtmael, S. A. Danner, P. H. Savelkoul, and C. M. Vandenbroucke-Grauls. 2004. New developments in the diagnosis of bloodstream infection. Lancet Infect. Dis.4:751-760.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    Romero-Vivas, J., M. Rubio, C. Fernandez, and J. J. Picazo. 1995. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis.21:1417-1423.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    Ruimy, R., L. Armand-Lefevre, and A. Andremont. 2005. Short time to positivity in blood culture with clustered gram-positive cocci on direct smear examination is highly predictive of Staphylococcus aureus. Am. J. Infect. Control33:304-306.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis.39:309-317.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    Wisplinghoff, H., H. Seifert, M. Coimbra, R. P. Wenzel, and M. B. Edmond. 2001. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Staphylococcus aureus. Clin. Infect. Dis.33:733-736.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Time to Blood Culture Positivity as a Predictor of Clinical Outcome of Staphylococcus aureus Bloodstream Infection
Alexandre R. Marra, Michael B. Edmond, Betty A. Forbes, Richard P. Wenzel, Gonzalo M. L. Bearman
Journal of Clinical Microbiology Apr 2006, 44 (4) 1342-1346; DOI: 10.1128/JCM.44.4.1342-1346.2006

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Time to Blood Culture Positivity as a Predictor of Clinical Outcome of Staphylococcus aureus Bloodstream Infection
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Time to Blood Culture Positivity as a Predictor of Clinical Outcome of Staphylococcus aureus Bloodstream Infection
Alexandre R. Marra, Michael B. Edmond, Betty A. Forbes, Richard P. Wenzel, Gonzalo M. L. Bearman
Journal of Clinical Microbiology Apr 2006, 44 (4) 1342-1346; DOI: 10.1128/JCM.44.4.1342-1346.2006
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

bacteremia
sepsis
Staphylococcal Infections
Staphylococcus aureus

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X